Patents by Inventor Thomas Daggs

Thomas Daggs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Room temperature stable oral calcitonin formulation
    Patent number: 11998640
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Grant
    Filed: February 18, 2022
    Date of Patent: June 4, 2024
    Assignees: Park Therapeutics, Inc., Enteris Biopharma, Inc.
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • ROOM TEMPERATURE STABLE ORAL CALCITONIN FORMULATION
    Publication number: 20230000779
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Application
    Filed: February 18, 2022
    Publication date: January 5, 2023
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • Room temperature stable oral calcitonin formulation
    Patent number: 11285113
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: March 29, 2022
    Assignees: TAURUS DEVELOPMENT COMPANY LLC, ENTERIS BIOPHARMA, INC.
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • ROOM TEMPERATURE STABLE ORAL CALCITONIN FORMULATION
    Publication number: 20190192442
    Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
    Type: Application
    Filed: February 5, 2019
    Publication date: June 27, 2019
    Inventors: James P. Gilligan, George R. Maurer, Aniruddha M. Railkar, Phillip Bauer, Thomas A. Daggs, Paul P. Shields
  • Solid Oral Dosage Forms
    Publication number: 20180049987
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery of active agent, such as peptides and small molecules, and methods for treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance the bioavailability of therapeutic active agents.
    Type: Application
    Filed: November 3, 2017
    Publication date: February 22, 2018
    Inventors: John Vrettos, Thomas Daggs, Paul Shields, Raymundo Claudio
  • Solid oral dosage forms
    Patent number: 9833411
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery of active agent, such as peptides and small molecules, and methods for treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance the bioavailability of therapeutic active agents.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: December 5, 2017
    Assignee: Enteris BioPharma, Inc.
    Inventors: John Vrettos, Thomas Daggs, Paul Shields, Raymundo Claudio
  • Solid Oral Dosage Forms
    Publication number: 20160199303
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery of active agent, such as peptides and small molecules, and methods for treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance the bioavailability of therapeutic active agents.
    Type: Application
    Filed: January 12, 2016
    Publication date: July 14, 2016
    Inventors: John Vrettos, Thomas Daggs, Paul Shields, Raymundo Claudio